Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Bruel AL"" wg kryterium: Autor


Wyświetlanie 1-10 z 10
Tytuł:
Cost of exome analysis in patients with intellectual disability: a micro-costing study in a French setting
Autorzy:
Soilly, ALAff1, Aff2
Robert-Viard, CAff2, Aff3
Besse, C
Bruel, AL
Gerard, B
Boland, A
Piton, A
Duffourd, Y
Muller, JAff6, Aff7, Aff8
Poë, C
Jouan, T
El Doueiri, S
Faivre, LAff5, Aff10
Bacq-Daian, D
Isidor, B
Genevieve, D
Odent, SAff13, Aff14
Philip, N
Doco-Fenzy, MAff16, Aff17
Lacombe, D
Asensio, ML
Deleuze, JF
Binquet, C
Thauvin-Robinet, CAff5, Aff10
Lejeune, CAff3, IDs1291302309373z_cor26
Pokaż więcej
Źródło:
BMC Health Services Research. 23(1)
Czasopismo naukowe
Tytuł:
Lessons from two series by physicians and caregivers' self-reported data in DDX3X-related disorders.
Autorzy:
Ruault V; Genetic Department, Montpellier University, INSERM Unit 1183, Montpellier, France.; Reference Center for Rare Diseases Developmental Anomaly and Malformative Syndromes, Genetics Department, Montpellier Hospital, Montpellier, France.
Burger P; Institute of Genetics and Molecular and Cellular Biology (IGBMC), Université de Strasbourg, INSERM U1258, CNRS UMR7104, Illkirch, France.
Gradels-Hauguel J; Center for Rare Psychiatric Disorders - GHU Paris Psychiatrie et Neurosciences - Paris - France APHP, GHU Sainte Anne, Paris, France.
Ruiz N; Genetic Department, Montpellier University, INSERM Unit 1183, Montpellier, France.; Reference Center for Rare Diseases Developmental Anomaly and Malformative Syndromes, Genetics Department, Montpellier Hospital, Montpellier, France.
Jamra RA; Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
Afenjar A; Département de Génétique Paris, Centre de Référence Malformations et maladies congénitales du cervelet et déficiences intellectuelles de causes rares, APHP, Sorbonne Université, Paris, France.
Alembik Y; Service de Génétique Médicale, Institut de Génétique Médicale d'Alsace, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Alessandri JL; CHU La Réunion, Service de génétique, Saint Denis, France.
Arpin S; Genetics Department, University Hospital, UMR1253 iBrain INSERM, University of Tours, Tours, France.
Barcia G; Service de Médecine Génomique des Maladies Rares, Hôpital Necker - Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France.
Bendová Š; Department of Biology and Medical Genetics, Charles University Second Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.
Bruel AL; Unité Fonctionnelle Innovation en Diagnostic Génomique des maladies rares, CHU Dijon Bourgogne, Dijon, France.; UFR Des Sciences de Santé, INSERM-Université de Bourgogne UMR1231 GAD 'Génétique des Anomalies du Développement', FHUTRANSLAD, Dijon, France.
Charles P; APHP La Pitié Salpétrière, Paris, France.
Chatron N; Department of Medical Genetics, University Hospital of Lyon and Claude Bernard Lyon I University, Lyon, France.; Pathophysiology and Genetics of Neuron and Muscle (PNMG), UCBL, CNRS UMR5261 - INSERM U1315, Lyon, France.
Chopra M; Department of Neurology, Rosamund Stone Zander Translational Neuroscience Center, Boston Children's Hospital, Boston, Massachusetts, USA.; Genetic Department, Harvard Medical School, Boston, Massachusetts, USA.
Conrad S; Genetic Department, CHU Nantes, Service de Génétique, Nantes, France.
Daire VC; Service de Médecine Génomique des Maladies Rares, Hôpital Necker - Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France.
Cospain A; Genetic Department, CHU Rennes, Service de Génétique, CLAD Ouest CRDI, Rennes, France.
Coubes C; Genetic Department, Montpellier University, INSERM Unit 1183, Montpellier, France.; Reference Center for Rare Diseases Developmental Anomaly and Malformative Syndromes, Genetics Department, Montpellier Hospital, Montpellier, France.
Coursimault J; Department of Genetics and Reference Center for Developmental Disorders, University of Rouen Normandie, Inserm U1245, CHU Rouen, Rouen, France.
Delahaye-Duriez A; Medical Genomics and Clinical Genetics Unit, AP-HP, Hôpital Jean Verdier, Bondy, France.; Genetic Department, UFR SMBH, Université Sorbonne Paris Nord, Paris, France.; Genetic Department, Inserm 1141 NeuroDiderot, Paris, France.
Doco M; Genetic Department, CHU Nantes, Service de Génétique, Nantes, France.; Centre Hospitalier Universitaire de Reims, Pôle de Biologie Médicale et Pathologie, Service de Génétique, Reims, France.
Dufour W; Department of Medical Genetics, University Hospital of Lyon and Claude Bernard Lyon I University, Lyon, France.
Durand B; Service de Génétique Médicale, Institut de Génétique Médicale d'Alsace, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Engel C; Oncobiologie Génétique Bioinformatique, PC BIO, CHU Besançon, Besançon, France.
Faivre L; Unité Fonctionnelle Innovation en Diagnostic Génomique des maladies rares, CHU Dijon Bourgogne, Dijon, France.; Centre de Génétique et Centre de référence maladies rares « Anomalies du Développement et Syndromes Malformatifs », FHU TRANSLAD, Hôpital d'Enfants, CHU Dijon, Dijon, France.
Ferroul F; CHU La Réunion, Service de génétique, Saint Denis, France.
Fradin M; Genetic Department, CHU Rennes, Service de Génétique, CLAD Ouest CRDI, Rennes, France.; CH Saint Brieuc, Service de Génétique, Saint Brieux, France.
Frenkiel H; Xtraordinaire Association, Paris, France.
Fusco C; Child Neurology and Psychiatry Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Garavelli L; Medical Genetics Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Garde A; Unité Fonctionnelle Innovation en Diagnostic Génomique des maladies rares, CHU Dijon Bourgogne, Dijon, France.; Centre de Génétique et Centre de référence maladies rares « Anomalies du Développement et Syndromes Malformatifs », FHU TRANSLAD, Hôpital d'Enfants, CHU Dijon, Dijon, France.
Gerard B; Service de Génétique Médicale, Institut de Génétique Médicale d'Alsace, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Germanaud D; Genetic Department, CEA Paris-Saclay, NeuroSpin, Gif-sur-Yvette, France.; Département de Génétique, Centre de référence Déficiences intellectuelles de causes rares, Assistance publique-Hopitaux de Paris (AP-HP), Hopital Robert-Debré, Paris, France.
Goujon L; Genetic Department, CEA Paris-Saclay, NeuroSpin, Gif-sur-Yvette, France.; Département de Génétique, Centre de référence Déficiences intellectuelles de causes rares, Assistance publique-Hopitaux de Paris (AP-HP), Hopital Robert-Debré, Paris, France.
Gouronc A; Service de Génétique Médicale, Institut de Génétique Médicale d'Alsace, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Ginglinger E; Génétique médicale GHRMSA, Hopital Emile Muller, Mulhouse, France.
Goldenberg A; Department of Genetics and Reference Center for Developmental Disorders, University of Rouen Normandie, Inserm U1245, CHU Rouen, Rouen, France.
Hancarova M; Department of Biology and Medical Genetics, Charles University Second Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.
Havlovicová M; Department of Biology and Medical Genetics, Charles University Second Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.
Heron D; APHP Trousseau, Paris, France.
Isidor B; Genetic Department, CHU Nantes, Service de Génétique, Nantes, France.
Marçais NJ; Genetic Department, CHU Rennes, Service de Génétique, CLAD Ouest CRDI, Rennes, France.
Keren B; Département de Génétique, Centre de Référence Déficiences Intellectuelles de Causes Rares, APHP Sorbonne Université, Paris, France.
Koch-Hogrebe M; Institute of Human Genetics, Medical Faculty, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Kuentz P; UFR Des Sciences de Santé, INSERM-Université de Bourgogne UMR1231 GAD 'Génétique des Anomalies du Développement', FHUTRANSLAD, Dijon, France.; Oncobiologie Génétique Bioinformatique, PC BIO, CHU Besançon, Besançon, France.
Lamure V; Genetic Department, UFR SMBH, Université Sorbonne Paris Nord, Paris, France.
Lebre AS; Centre Hospitalier Universitaire de Reims, Pôle de Biologie Médicale et Pathologie, Service de Génétique, Reims, France.; Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Université Paris Cité, Paris, France.
Lecoquierre F; Department of Genetics and Reference Center for Developmental Disorders, University of Rouen Normandie, Inserm U1245, CHU Rouen, Rouen, France.
Lehman N; Genetic Department, Montpellier University, INSERM Unit 1183, Montpellier, France.; Reference Center for Rare Diseases Developmental Anomaly and Malformative Syndromes, Genetics Department, Montpellier Hospital, Montpellier, France.
Lesca G; Department of Medical Genetics, University Hospital of Lyon and Claude Bernard Lyon I University, Lyon, France.; Pathophysiology and Genetics of Neuron and Muscle (PNMG), UCBL, CNRS UMR5261 - INSERM U1315, Lyon, France.
Lyonnet S; Service de Médecine Génomique des Maladies Rares, Hôpital Necker - Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France.; Laboratoire Embryologie et Génétique des Malformations, Université Paris Cité, INSERM, IHU Imagine - Institut des maladies génétiques, Paris, France.
Martin D; Xtraordinaire Association, Paris, France.
Mignot C; Département de Génétique, Centre de Référence Déficiences Intellectuelles de Causes Rares, APHP Sorbonne Université, Paris, France.
Neuhann TM; Genetic Department, Medizinisch Genetisches Zentrum, Munich, Germany.
Nicolas G; Department of Genetics and Reference Center for Developmental Disorders, University of Rouen Normandie, Inserm U1245, CHU Rouen, Rouen, France.
Nizon M; Genetic Department, CHU Nantes, Service de Génétique, Nantes, France.
Petit F; Genetic Department, CHU Lille, Clinique de Génétique Guy Fontaine, Lille, France.
Philippe C; Unité Fonctionnelle Innovation en Diagnostic Génomique des maladies rares, CHU Dijon Bourgogne, Dijon, France.; UFR Des Sciences de Santé, INSERM-Université de Bourgogne UMR1231 GAD 'Génétique des Anomalies du Développement', FHUTRANSLAD, Dijon, France.
Piton A; Service de Génétique Médicale, Institut de Génétique Médicale d'Alsace, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Pollazzon M; Medical Genetics Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Prchalová D; Department of Biology and Medical Genetics, Charles University Second Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.
Putoux A; Department of Medical Genetics, University Hospital of Lyon and Claude Bernard Lyon I University, Lyon, France.; INSERM U1028, CNRS UMR5292, Centre de Recherche en Neurosciences de Lyon, GENDEV Team, Université Claude Bernard Lyon 1, Bron, France.
Rio M; Service de Médecine Génomique des Maladies Rares, Hôpital Necker - Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France.
Rondeau S; Service de Médecine Génomique des Maladies Rares, Hôpital Necker - Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France.
Rossi M; Department of Medical Genetics, University Hospital of Lyon and Claude Bernard Lyon I University, Lyon, France.; INSERM U1028, CNRS UMR5292, Centre de Recherche en Neurosciences de Lyon, GENDEV Team, Université Claude Bernard Lyon 1, Bron, France.
Sabbagh Q; Genetic Department, Montpellier University, INSERM Unit 1183, Montpellier, France.; Reference Center for Rare Diseases Developmental Anomaly and Malformative Syndromes, Genetics Department, Montpellier Hospital, Montpellier, France.
Saugier-Veber P; Department of Genetics and Reference Center for Developmental Disorders, University of Rouen Normandie, Inserm U1245, CHU Rouen, Rouen, France.
Schmetz A; Institute of Human Genetics, Medical Faculty, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Steffann J; Service de Médecine Génomique des Maladies Rares, Hôpital Necker - Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France.
Thauvin-Robinet C; Unité Fonctionnelle Innovation en Diagnostic Génomique des maladies rares, CHU Dijon Bourgogne, Dijon, France.; UFR Des Sciences de Santé, INSERM-Université de Bourgogne UMR1231 GAD 'Génétique des Anomalies du Développement', FHUTRANSLAD, Dijon, France.; Centre de Génétique et Centre de référence maladies rares « Anomalies du Développement et Syndromes Malformatifs », FHU TRANSLAD, Hôpital d'Enfants, CHU Dijon, Dijon, France.
Toutain A; Genetics Department, University Hospital, UMR1253 iBrain INSERM, University of Tours, Tours, France.
Them FTM; Unité Fonctionnelle Innovation en Diagnostic Génomique des maladies rares, CHU Dijon Bourgogne, Dijon, France.; UFR Des Sciences de Santé, INSERM-Université de Bourgogne UMR1231 GAD 'Génétique des Anomalies du Développement', FHUTRANSLAD, Dijon, France.
Trimarchi G; Medical Genetics Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Vincent M; Genetic Department, CHU Nantes, Service de Génétique, Nantes, France.
Vlčková M; Department of Biology and Medical Genetics, Charles University Second Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.
Wieczorek D; Institute of Human Genetics, Medical Faculty, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Willems M; Genetic Department, Montpellier University, INSERM Unit 1183, Montpellier, France.; Reference Center for Rare Diseases Developmental Anomaly and Malformative Syndromes, Genetics Department, Montpellier Hospital, Montpellier, France.
Yauy K; Genetic Department, Montpellier University, INSERM Unit 1183, Montpellier, France.; Reference Center for Rare Diseases Developmental Anomaly and Malformative Syndromes, Genetics Department, Montpellier Hospital, Montpellier, France.
Zelinová M; Department of Biology and Medical Genetics, Charles University Second Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.
Ziegler A; Genetic Department, Service de Génétique, CHU d'Angers, Angers Cedex 9, France.
Chaumette B; Center for Rare Psychiatric Disorders - GHU Paris Psychiatrie et Neurosciences - Paris - France APHP, GHU Sainte Anne, Paris, France.; Institute of Psychiatry and Neuroscience of Paris, Université Paris Cité, INSERM U1266, Paris, France.; Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Sadikovic B; Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.; Verspeeten Clinical Genome Centre, London Health Sciences Centre, London, Ontario, Canada.
Mandel JL; Institute of Genetics and Molecular and Cellular Biology (IGBMC), Université de Strasbourg, INSERM U1258, CNRS UMR7104, Illkirch, France.; Genetic Department, University of Strasbourg Institute for Advanced Studies (USIAS), Strasbourg, France.
Geneviève D; Genetic Department, Montpellier University, INSERM Unit 1183, Montpellier, France.; Reference Center for Rare Diseases Developmental Anomaly and Malformative Syndromes, Genetics Department, Montpellier Hospital, Montpellier, France.
Pokaż więcej
Corporate Authors:
Xtraordinaire; Xtraordinaire Association, Paris, France.
GENIDA Project; Institute of Genetics and Molecular and Cellular Biology (IGBMC), Université de Strasbourg, INSERM U1258, CNRS UMR7104, Illkirch, France.
Źródło:
Molecular genetics & genomic medicine [Mol Genet Genomic Med] 2024 Jan; Vol. 12 (1), pp. e2363.
Typ publikacji:
Journal Article
MeSH Terms:
Attention Deficit Disorder with Hyperactivity*/genetics
Attention Deficit Disorder with Hyperactivity*/therapy
Caregivers*
Child, Preschool ; Humans ; DEAD-box RNA Helicases ; Self Report ; Infant
Czasopismo naukowe
Tytuł:
DNA Methylation Signature for JARID2 -Neurodevelopmental Syndrome.
Autorzy:
Verberne EA; Department of Human Genetics, Amsterdam Reproduction & Development Research Institute, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
van der Laan L; Department of Human Genetics, Amsterdam Reproduction & Development Research Institute, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Haghshenas S; Department of Pathology and Laboratory Medicine, Western University, London, ON N6A 3K7, Canada.
Rooney K; Department of Pathology and Laboratory Medicine, Western University, London, ON N6A 3K7, Canada.; Verspeeten Clinical Genome Centre, London Health Sciences Centre, London, ON N6A 5W9, Canada.
Levy MA; Verspeeten Clinical Genome Centre, London Health Sciences Centre, London, ON N6A 5W9, Canada.
Alders M; Department of Human Genetics, Amsterdam Reproduction & Development Research Institute, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Maas SM; Department of Human Genetics, Amsterdam Reproduction & Development Research Institute, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Jansen S; Department of Human Genetics, Amsterdam Reproduction & Development Research Institute, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Lieden A; Department of Clinical Genetics, Karolinska University Hospital, 17176 Stockholm, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, 17176 Stockholm, Sweden.
Anderlid BM; Department of Clinical Genetics, Karolinska University Hospital, 17176 Stockholm, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, 17176 Stockholm, Sweden.
Rafael-Croes L; Department of Pediatrics, Dr. Horacio E. Oduber Hospital, Dr. Horacio E. Oduber Boulevard 1, Oranjestad, Aruba.
Campeau PM; Department of Pediatrics, University of Montreal, Montreal, QC H4A 3J1, Canada.
Chaudhry A; Department of Laboratory Medicine and Genetics, Trillium Health Partners, Mississauga, ON L5B 1B8, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.
Koolen DA; Department of Hum Genet, Radboud Institute for Molecular Life Sciences and Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Pfundt R; Department of Hum Genet, Radboud Institute for Molecular Life Sciences and Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Hurst ACE; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Tran-Mau-Them F; UF6254 Innovation en Diagnostic Genomique des Maladies Rares, 21070 Dijon, France.; Équipe Génétique des Anomalies du Développement (GAD), CHU Dijon-Bourgogne, 21000 Dijon, France.
Bruel AL; UF6254 Innovation en Diagnostic Genomique des Maladies Rares, 21070 Dijon, France.; Équipe Génétique des Anomalies du Développement (GAD), CHU Dijon-Bourgogne, 21000 Dijon, France.
Lambert L; Service de Génétique Clinique, CHRU Nancy, 54000 Nancy, France.
Isidor B; Service de génétique médicale, CHU de Nantes, 44000 Nantes, France.
Mannens MMAM; Department of Human Genetics, Amsterdam Reproduction & Development Research Institute, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Sadikovic B; Department of Pathology and Laboratory Medicine, Western University, London, ON N6A 3K7, Canada.; Verspeeten Clinical Genome Centre, London Health Sciences Centre, London, ON N6A 5W9, Canada.
Henneman P; Department of Human Genetics, Amsterdam Reproduction & Development Research Institute, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
van Haelst MM; Department of Human Genetics, Amsterdam Reproduction & Development Research Institute, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Jul 20; Vol. 23 (14). Date of Electronic Publication: 2022 Jul 20.
Typ publikacji:
Journal Article
MeSH Terms:
DNA Methylation*
Polycomb Repressive Complex 2*/genetics
Humans ; Nucleotide Motifs ; Phenotype ; Protein Processing, Post-Translational ; Syndrome
Czasopismo naukowe
Tytuł:
Copy number variants calling from WES data through eXome hidden Markov model (XHMM) identifies additional 2.5% pathogenic genomic imbalances smaller than 30 kb undetected by array-CGH.
Autorzy:
Tisserant E; Inserm UMR 1231 GAD, Faculty of Health Sciences, University of Burgundy and Franche-Comté, Dijon, France.
Vitobello A; Inserm UMR 1231 GAD, Faculty of Health Sciences, University of Burgundy and Franche-Comté, Dijon, France.; Molecular and chromosomal genetics laboratory, Biology Transfer Platform, Dijon University Hospital, Dijon, France.
Callegarin D; Molecular and chromosomal genetics laboratory, Biology Transfer Platform, Dijon University Hospital, Dijon, France.
Verdez S; Molecular and chromosomal genetics laboratory, Biology Transfer Platform, Dijon University Hospital, Dijon, France.
Bruel AL; Inserm UMR 1231 GAD, Faculty of Health Sciences, University of Burgundy and Franche-Comté, Dijon, France.
Aho Glele LS; Hospital Hygiene and Epidemiology Unit, Dijon University Hospital, Dijon Cedex, France.
Sorlin A; Inserm UMR 1231 GAD, Faculty of Health Sciences, University of Burgundy and Franche-Comté, Dijon, France.; Molecular and chromosomal genetics laboratory, Biology Transfer Platform, Dijon University Hospital, Dijon, France.
Viora-Dupont E; Molecular and chromosomal genetics laboratory, Biology Transfer Platform, Dijon University Hospital, Dijon, France.
Konyukh M; Molecular and chromosomal genetics laboratory, Biology Transfer Platform, Dijon University Hospital, Dijon, France.
Marle N; Molecular and chromosomal genetics laboratory, Biology Transfer Platform, Dijon University Hospital, Dijon, France.
Nambot S; Inserm UMR 1231 GAD, Faculty of Health Sciences, University of Burgundy and Franche-Comté, Dijon, France.; Hospital Hygiene and Epidemiology Unit, Dijon University Hospital, Dijon Cedex, France.
Moutton S; Inserm UMR 1231 GAD, Faculty of Health Sciences, University of Burgundy and Franche-Comté, Dijon, France.; Molecular and chromosomal genetics laboratory, Biology Transfer Platform, Dijon University Hospital, Dijon, France.; Reference Center for Intellectual Disorders, Dijon University Hospital, Dijon, France.
Racine C; Inserm UMR 1231 GAD, Faculty of Health Sciences, University of Burgundy and Franche-Comté, Dijon, France.; Molecular and chromosomal genetics laboratory, Biology Transfer Platform, Dijon University Hospital, Dijon, France.; Genetics Department and Reference Center for Developmental Disorders and Malformative Syndromes for East France, FHU TRANSLAD, Dijon University Hospital, Dijon, France.
Garde A; Inserm UMR 1231 GAD, Faculty of Health Sciences, University of Burgundy and Franche-Comté, Dijon, France.; Molecular and chromosomal genetics laboratory, Biology Transfer Platform, Dijon University Hospital, Dijon, France.
Delanne J; Inserm UMR 1231 GAD, Faculty of Health Sciences, University of Burgundy and Franche-Comté, Dijon, France.; Genetics Department and Reference Center for Developmental Disorders and Malformative Syndromes for East France, FHU TRANSLAD, Dijon University Hospital, Dijon, France.
Tran-Mau-Them F; Inserm UMR 1231 GAD, Faculty of Health Sciences, University of Burgundy and Franche-Comté, Dijon, France.
Philippe C; Inserm UMR 1231 GAD, Faculty of Health Sciences, University of Burgundy and Franche-Comté, Dijon, France.; Molecular and chromosomal genetics laboratory, Biology Transfer Platform, Dijon University Hospital, Dijon, France.
Kuentz P; Inserm UMR 1231 GAD, Faculty of Health Sciences, University of Burgundy and Franche-Comté, Dijon, France.
Poulleau M; Molecular and chromosomal genetics laboratory, Biology Transfer Platform, Dijon University Hospital, Dijon, France.
Payet M; Molecular and chromosomal genetics laboratory, Biology Transfer Platform, Dijon University Hospital, Dijon, France.
Poe C; Inserm UMR 1231 GAD, Faculty of Health Sciences, University of Burgundy and Franche-Comté, Dijon, France.
Thauvin-Robinet C; Inserm UMR 1231 GAD, Faculty of Health Sciences, University of Burgundy and Franche-Comté, Dijon, France.; Genetics Department and Reference Center for Developmental Disorders and Malformative Syndromes for East France, FHU TRANSLAD, Dijon University Hospital, Dijon, France.; Reference Center for Intellectual Disorders, Dijon University Hospital, Dijon, France.
Faivre L; Inserm UMR 1231 GAD, Faculty of Health Sciences, University of Burgundy and Franche-Comté, Dijon, France.; Genetics Department and Reference Center for Developmental Disorders and Malformative Syndromes for East France, FHU TRANSLAD, Dijon University Hospital, Dijon, France.; Reference Center for Intellectual Disorders, Dijon University Hospital, Dijon, France.
Mosca-Boidron AL; Inserm UMR 1231 GAD, Faculty of Health Sciences, University of Burgundy and Franche-Comté, Dijon, France.; Molecular and chromosomal genetics laboratory, Biology Transfer Platform, Dijon University Hospital, Dijon, France.
Thevenon J; Inserm UMR 1231 GAD, Faculty of Health Sciences, University of Burgundy and Franche-Comté, Dijon, France.; Genetics Department and Reference Center for Developmental Disorders and Malformative Syndromes for East France, FHU TRANSLAD, Dijon University Hospital, Dijon, France.
Duffourd Y; Inserm UMR 1231 GAD, Faculty of Health Sciences, University of Burgundy and Franche-Comté, Dijon, France.
Callier P; Inserm UMR 1231 GAD, Faculty of Health Sciences, University of Burgundy and Franche-Comté, Dijon, France.; Molecular and chromosomal genetics laboratory, Biology Transfer Platform, Dijon University Hospital, Dijon, France.
Pokaż więcej
Źródło:
Annals of human genetics [Ann Hum Genet] 2022 Jul; Vol. 86 (4), pp. 171-180. Date of Electronic Publication: 2022 Feb 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Exome*
Intellectual Disability*/genetics
Comparative Genomic Hybridization ; DNA Copy Number Variations ; Genomics ; Humans ; Exome Sequencing
Czasopismo naukowe
Tytuł:
Atypical phenotype of a patient with Bardet-Biedl syndrome type 4.
Autorzy:
Sloboda N; Service de Génétique Clinique, CHRU Nancy, Nancy, France.
Lambert L; Service de Génétique Clinique, CHRU Nancy, Nancy, France.
Ciorna V; Service de Génétique, CHR Metz-Thionville, France.
Bruel AL; Laboratoire de génétique, Innovation en diagnostic génomique des maladies rares UF6254, Plate-forme de Biologie Hospitalo-Universitaire, CHU Dijon, Dijon, France.
Tran Mau-Them F; Laboratoire de génétique, Innovation en diagnostic génomique des maladies rares UF6254, Plate-forme de Biologie Hospitalo-Universitaire, CHU Dijon, Dijon, France.; INSERM U1231, LNC UMR1231 GAD, Université de Bourgogne, Dijon, France.
Gomola V; Service de Chirurgie Viscérale Infantile, CHRU Nancy, Nancy, France.
Lemelle JL; Service de Chirurgie Viscérale Infantile, CHRU Nancy, Nancy, France.
Klein O; Service de Neurochirurgie Pédiatrique, CHRU Nancy, Nancy, France.
Camoin-Schweitzer MC; Service de néphrologie pédiatrique, dialyse, transplantation rénale, CHRU Nancy, Nancy, France.
Magnavacca M; Service de néphrologie pédiatrique, dialyse, transplantation rénale, CHRU Nancy, Nancy, France.
Legagneur C; Unité d'Endocrinologie Pédiatrique et Diabétologie, CHRU Nancy, Nancy, France.
Ezsto ML; Service de Gynécologie-Obstétrique, CHR Metz-Thionville, France.
Bonnet C; Laboratoire de Génétique, CHRU Nancy, Nancy, France.
Philippe C; Laboratoire de génétique, Innovation en diagnostic génomique des maladies rares UF6254, Plate-forme de Biologie Hospitalo-Universitaire, CHU Dijon, Dijon, France.; INSERM U1231, LNC UMR1231 GAD, Université de Bourgogne, Dijon, France.
Leheup B; Service de Génétique Clinique, CHRU Nancy, Nancy, France.
Pokaż więcej
Źródło:
Molecular genetics & genomic medicine [Mol Genet Genomic Med] 2022 May; Vol. 10 (5), pp. e1869. Date of Electronic Publication: 2022 Mar 23.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Bardet-Biedl Syndrome*/diagnosis
Polydactyly*/genetics
Female ; Humans ; Male ; Phenotype ; Exome Sequencing
SCR Disease Name:
Bardet-Biedl syndrome 4
Czasopismo naukowe
Tytuł:
Interest of exome sequencing trio-like strategy based on pooled parental DNA for diagnosis and translational research in rare diseases.
Autorzy:
Tran Mau-Them F; Unité Fonctionnelle 6254 d'Innovation en Diagnostique Génomique des Maladies Rares, Pôle de Biologie, CHU Dijon Bourgogne, Dijon, France.; Inserm - Université de Bourgogne UMR1231 GAD, FHU-TRANSLAD, Dijon, France.
Duffourd Y; Inserm - Université de Bourgogne UMR1231 GAD, FHU-TRANSLAD, Dijon, France.; FHU-TRANSLAD, Dijon, France.
Vitobello A; Unité Fonctionnelle 6254 d'Innovation en Diagnostique Génomique des Maladies Rares, Pôle de Biologie, CHU Dijon Bourgogne, Dijon, France.; Inserm - Université de Bourgogne UMR1231 GAD, FHU-TRANSLAD, Dijon, France.
Bruel AL; Unité Fonctionnelle 6254 d'Innovation en Diagnostique Génomique des Maladies Rares, Pôle de Biologie, CHU Dijon Bourgogne, Dijon, France.; Inserm - Université de Bourgogne UMR1231 GAD, FHU-TRANSLAD, Dijon, France.
Denommé-Pichon AS; Unité Fonctionnelle 6254 d'Innovation en Diagnostique Génomique des Maladies Rares, Pôle de Biologie, CHU Dijon Bourgogne, Dijon, France.; Inserm - Université de Bourgogne UMR1231 GAD, FHU-TRANSLAD, Dijon, France.
Nambot S; Centre de Référence Maladies Rares « Anomalies du Développement et Syndrome Malformatifs » de l'Est, Hôpital d'Enfants, CHU Dijon Bourgogne, Dijon, France.
Delanne J; Centre de Référence Maladies Rares « Anomalies du Développement et Syndrome Malformatifs » de l'Est, Hôpital d'Enfants, CHU Dijon Bourgogne, Dijon, France.
Moutton S; Centre de Référence Maladies Rares « Anomalies du Développement et Syndrome Malformatifs » de l'Est, Hôpital d'Enfants, CHU Dijon Bourgogne, Dijon, France.
Sorlin A; Centre de Référence Maladies Rares « Anomalies du Développement et Syndrome Malformatifs » de l'Est, Hôpital d'Enfants, CHU Dijon Bourgogne, Dijon, France.
Couturier V; Unité Fonctionnelle 6254 d'Innovation en Diagnostique Génomique des Maladies Rares, Pôle de Biologie, CHU Dijon Bourgogne, Dijon, France.; Inserm - Université de Bourgogne UMR1231 GAD, FHU-TRANSLAD, Dijon, France.
Bourgeois V; Unité Fonctionnelle 6254 d'Innovation en Diagnostique Génomique des Maladies Rares, Pôle de Biologie, CHU Dijon Bourgogne, Dijon, France.; Inserm - Université de Bourgogne UMR1231 GAD, FHU-TRANSLAD, Dijon, France.
Chevarin M; Unité Fonctionnelle 6254 d'Innovation en Diagnostique Génomique des Maladies Rares, Pôle de Biologie, CHU Dijon Bourgogne, Dijon, France.; Inserm - Université de Bourgogne UMR1231 GAD, FHU-TRANSLAD, Dijon, France.
Poe C; Unité Fonctionnelle 6254 d'Innovation en Diagnostique Génomique des Maladies Rares, Pôle de Biologie, CHU Dijon Bourgogne, Dijon, France.; Inserm - Université de Bourgogne UMR1231 GAD, FHU-TRANSLAD, Dijon, France.
Mosca-Boidron AL; Laboratoire de Génétique Chromosomique et Moléculaire, CHU de Dijon, France.
Callier P; Laboratoire de Génétique Chromosomique et Moléculaire, CHU de Dijon, France.
Safraou H; Unité Fonctionnelle 6254 d'Innovation en Diagnostique Génomique des Maladies Rares, Pôle de Biologie, CHU Dijon Bourgogne, Dijon, France.; Inserm - Université de Bourgogne UMR1231 GAD, FHU-TRANSLAD, Dijon, France.
Faivre L; Inserm - Université de Bourgogne UMR1231 GAD, FHU-TRANSLAD, Dijon, France.; Centre de Référence Maladies Rares « Anomalies du Développement et Syndrome Malformatifs » de l'Est, Hôpital d'Enfants, CHU Dijon Bourgogne, Dijon, France.
Philippe C; Unité Fonctionnelle 6254 d'Innovation en Diagnostique Génomique des Maladies Rares, Pôle de Biologie, CHU Dijon Bourgogne, Dijon, France.; Inserm - Université de Bourgogne UMR1231 GAD, FHU-TRANSLAD, Dijon, France.
Thauvin-Robinet C; Unité Fonctionnelle 6254 d'Innovation en Diagnostique Génomique des Maladies Rares, Pôle de Biologie, CHU Dijon Bourgogne, Dijon, France.; Inserm - Université de Bourgogne UMR1231 GAD, FHU-TRANSLAD, Dijon, France.; FHU-TRANSLAD, Dijon, France.; Centre de Référence Maladies Rares «Déficiences Intellectuelles de Causes Rares», Hôpital d'Enfants, CHU Dijon Bourgogne, Dijon, France.
Pokaż więcej
Corporate Authors:
Orphanomix Physician’s Group; FHU-TRANSLAD, Dijon, France.
Źródło:
Molecular genetics & genomic medicine [Mol Genet Genomic Med] 2021 Dec; Vol. 9 (12), pp. e1836. Date of Electronic Publication: 2021 Oct 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Genetic Predisposition to Disease*
Genetic Testing*
Translational Research, Biomedical*/methods
Translational Research, Biomedical*/standards
Exome Sequencing*/methods
Exome Sequencing*/standards
Rare Diseases/*diagnosis
Rare Diseases/*genetics
Genetic Markers ; Genome-Wide Association Study ; Humans ; Reproducibility of Results ; Research Design ; Sensitivity and Specificity ; Sequence Analysis, DNA ; Workflow
Czasopismo naukowe
Tytuł:
EIF3F-related neurodevelopmental disorder: refining the phenotypic and expanding the molecular spectrum.
Autorzy:
Hüffmeier U; Institute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Schwabachanlage 10, 91054, Erlangen, Germany. .
Kraus C; Institute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Schwabachanlage 10, 91054, Erlangen, Germany.
Reuter MS; Institute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Schwabachanlage 10, 91054, Erlangen, Germany.
Uebe S; Institute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Schwabachanlage 10, 91054, Erlangen, Germany.
Abbott MA; Medical Genetics, Department of Pediatrics, University of Massachusetts Medical School - Baystate, Springfield, MA, USA.
Ahmed SA; Department of Genetics, Southern California Permanente Medical Group, Kaiser Permanente, Riverside, CA, USA.
Rawson KL; Department of Genetics, Southern California Permanente Medical Group, Kaiser Permanente, Riverside, CA, USA.
Barr E; Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, 30322, USA.
Li H; Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, 30322, USA.
Bruel AL; UMR-Inserm 1231 GAD Team, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, 21000, Dijon, France.; Laboratoire de Génétique Chromosomique et Moléculaire, UF Innovation en diagnostic génomique des maladies rares, Plateau de Biologie Hospitalo-Universitaire, Centre Hospitalier Universitaire de Dijon, Dijon, France.
Faivre L; UMR-Inserm 1231 GAD Team, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, 21000, Dijon, France.; Centre de Génétique, Centre de Référence «Anomalies du Développement et Syndromes Malformatifs» et FHU TRANSLAD, Hôpital D'Enfants, Centre Hospitalier Universitaire de Dijon, Dijon, France.
Tran Mau-Them F; UMR-Inserm 1231 GAD Team, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, 21000, Dijon, France.; Laboratoire de Génétique Chromosomique et Moléculaire, UF Innovation en diagnostic génomique des maladies rares, Plateau de Biologie Hospitalo-Universitaire, Centre Hospitalier Universitaire de Dijon, Dijon, France.
Botti C; Division of Medical Genetics, Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, 08901, USA.
Brooks S; Division of Medical Genetics, Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, 08901, USA.
Burns K; Sanford Health, Sioux Falls, SD, USA.
Ward DI; Sanford Health, Sioux Falls, SD, USA.
Dutra-Clarke M; Division of Genetics, Department of Pediatrics, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Martinez-Agosto JA; Division of Genetics, Department of Pediatrics, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.; Department of Human Genetics, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Lee H; Department of Human Genetics, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.; Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Nelson SF; Division of Genetics, Department of Pediatrics, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.; Department of Human Genetics, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.; Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Zacher P; Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.; Epilepsy Center Kleinwachau, Radeberg, Germany.
Abou Jamra R; Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
Klöckner C; Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
McGaughran J; Genetic Health Queensland, Royal Brisbane and Woman's Hospital, Brisbane, Australia.; School of Medicine, The University of Queensland, St Lucia, Brisbane, Australia.
Kohlhase J; Synlab Human Genetics Freiburg, Freiburg, Germany.
Schuhmann S; Institute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Schwabachanlage 10, 91054, Erlangen, Germany.
Moran E; Clinical Genetics, Hassenfeld Children's Hospital at NYU Langone, NYU Langone, Orthopedic Hospital, New York, NY, USA.
Pappas J; Division of Clinical Genetic Services, Department of Pediatrics, NYU Grossman School of Medicine, New York, NY, USA.
Raas-Rothschild A; Sackler School of Medicine at Tel Aviv University, Tel Aviv, Israel.; Institute of Rare Diseases, Edmond & Lily Safra Children Hospital, Tel Hashomer, Israel.
Sacoto MJG; GeneDx, Gaithersburg, MD, 20877, USA.
Henderson LB; GeneDx, Gaithersburg, MD, 20877, USA.
Palculict TB; GeneDx, Gaithersburg, MD, 20877, USA.
Mullegama SV; GeneDx, Gaithersburg, MD, 20877, USA.
Zghal Elloumi H; GeneDx, Gaithersburg, MD, 20877, USA.
Reich A; GeneDx, Gaithersburg, MD, 20877, USA.
Schrier Vergano SA; Division of Medical Genetics and Metabolism, Children's Hospital of The King's Daughters, Norfolk, VA, USA.
Wahl E; Division of Genetics, UBMD Pediatrics, Buffalo, NY, USA.
Reis A; Institute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Schwabachanlage 10, 91054, Erlangen, Germany.
Zweier C; Institute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Schwabachanlage 10, 91054, Erlangen, Germany.; Department of Human Genetics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Pokaż więcej
Corporate Authors:
UCLA California Center for Rare Disease
Źródło:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2021 Mar 18; Vol. 16 (1), pp. 136. Date of Electronic Publication: 2021 Mar 18.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Cleft Lip*
Cleft Palate*
Intellectual Disability*/genetics
Microcephaly*
Neurodevelopmental Disorders*/genetics
Eukaryotic Initiation Factor-3 ; Humans
Czasopismo naukowe
Tytuł:
Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
Autorzy:
Kim HG; 1Neurological Disorders Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Doha, Qatar.
Rosenfeld JA; 2Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX USA.
Scott DA; 2Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX USA.; 3Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX USA.
Bénédicte G; 4Laboratoires de Diagnostic Génétique, Unité de génétique moléculaire, Nouvel Hôpital Civil, Strasbourg Cedex, France.
Labonne JD; 5Section of Reproductive Endocrinology, Infertility & Genetics, Department of Obstetrics & Gynecology, Augusta University, Augusta, GA USA.
Brown J; 5Section of Reproductive Endocrinology, Infertility & Genetics, Department of Obstetrics & Gynecology, Augusta University, Augusta, GA USA.
McGuire M; Baylor Genetic Laboratories, Houston, TX USA.
Mahida S; 7Kennedy Krieger Institute, Baltimore, MD USA.
Naidu S; 7Kennedy Krieger Institute, Baltimore, MD USA.
Gutierrez J; 3Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX USA.
Lesca G; 8Department of Medical Genetics, Lyon University Hospital, Lyon, France.
des Portes V; 9Department of Pediatric Neurology, Lyon University Hospital, Lyon, France.
Bruel AL; 10Équipe Génétique des Anomalies du Développement (GAD), INSERM, Dijon, France.
Sorlin A; Centre de Génétique, CHU Dijon Bourgogne, Dijon, France.
Xia F; 2Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX USA.
Capri Y; Service de Génétique Clinique, CHU Robert Debré, Paris, France.
Muller E; 13Clinical Genetics, Stanford Children's Health at CPMC, San Francisco, CA USA.
McKnight D; 14GeneDx, Gaithersburg, MD USA.
Torti E; 14GeneDx, Gaithersburg, MD USA.
Rüschendorf F; 15Max Delbrück Center (MDC) for Molecular Medicine, Berlin, Germany.
Hummel O; 15Max Delbrück Center (MDC) for Molecular Medicine, Berlin, Germany.
Islam Z; 16Diabetes Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University, Doha, Qatar.
Kolatkar PR; 16Diabetes Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University, Doha, Qatar.
Layman LC; 5Section of Reproductive Endocrinology, Infertility & Genetics, Department of Obstetrics & Gynecology, Augusta University, Augusta, GA USA.; 17Department of Neuroscience and Regenerative Medicine, Augusta University, Augusta, GA USA.
Ryu D; 18Department of Statistics and Actuarial Science, Northern Illinois University, DeKalb, IL USA.
Kong IK; 19Department of Animal Science, Division of Applied Life Science (BK21plus), Gyeongsang National University, Jinju, Korea.
Madan-Khetarpal S; 20Pediatric Medical Genetics, Children's Hospital of Pittsburgh, Pittsburgh, PA USA.
Kim CH; 21Department of Biology, Chungnam National University, Daejeon, Korea.
Pokaż więcej
Źródło:
Molecular autism [Mol Autism] 2019 Oct 22; Vol. 10, pp. 35. Date of Electronic Publication: 2019 Oct 22 (Print Publication: 2019).
Typ publikacji:
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Behavior*
Autistic Disorder/*genetics
Craniofacial Abnormalities/*genetics
Epilepsy/*genetics
Histone Deacetylases/*genetics
Intellectual Disability/*genetics
Muscle Hypotonia/*genetics
Adolescent ; Amino Acid Sequence ; Autistic Disorder/complications ; Brain/metabolism ; Child ; Child, Preschool ; Craniofacial Abnormalities/complications ; Epilepsy/complications ; Female ; Histone Deacetylases/chemistry ; Histone Deacetylases/metabolism ; Humans ; Infant ; Infant, Newborn ; Intellectual Disability/complications ; Male ; Muscle Hypotonia/complications ; Mutation/genetics ; Protein Domains ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Syndrome
Czasopismo naukowe
Tytuł:
MKS5 and CEP290 Dependent Assembly Pathway of the Ciliary Transition Zone.
Autorzy:
Li C; Department of Molecular Biology and Biochemistry and Centre for Cell Biology, Development and Disease, Simon Fraser University, Burnaby, British Columbia, Canada.
Jensen VL; Department of Molecular Biology and Biochemistry and Centre for Cell Biology, Development and Disease, Simon Fraser University, Burnaby, British Columbia, Canada.
Park K; Department of Molecular Biology and Biochemistry and Centre for Cell Biology, Development and Disease, Simon Fraser University, Burnaby, British Columbia, Canada.
Kennedy J; School of Biomolecular & Biomedical Science, University College Dublin, Belfield, Dublin 4, Ireland.
Garcia-Gonzalo FR; Department of Biochemistry and Biophysics, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, United States of America.
Romani M; Neurogenetics Unit, Mendel Laboratory, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
De Mori R; Neurogenetics Unit, Mendel Laboratory, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Bruel AL; EA4271 GAD Génétique des Anomalies du Développement, FHU-TRANSLAD, Université Fédérale Bourgogne Franche-Comté, Dijon, France.
Gaillard D; Service de Génétique clinique, CHU Reims, Reims, France.
Doray B; Service de Génétique clinique, CHRU Strasbourg, Strasbourg, France.
Lopez E; EA4271 GAD Génétique des Anomalies du Développement, FHU-TRANSLAD, Université Fédérale Bourgogne Franche-Comté, Dijon, France.
Rivière JB; EA4271 GAD Génétique des Anomalies du Développement, FHU-TRANSLAD, Université Fédérale Bourgogne Franche-Comté, Dijon, France.; Laboratoire de Génétique moléculaire, Plateau Technique de Biologie, CHU Dijon, Dijon, France.
Faivre L; EA4271 GAD Génétique des Anomalies du Développement, FHU-TRANSLAD, Université Fédérale Bourgogne Franche-Comté, Dijon, France.; Centre de Génétique, FHU-TRANSLAD, Hôpital d'Enfants, CHU Dijon, Dijon, France.
Thauvin-Robinet C; EA4271 GAD Génétique des Anomalies du Développement, FHU-TRANSLAD, Université Fédérale Bourgogne Franche-Comté, Dijon, France.; Centre de Génétique, FHU-TRANSLAD, Hôpital d'Enfants, CHU Dijon, Dijon, France.
Reiter JF; Department of Biochemistry and Biophysics, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, United States of America.
Blacque OE; School of Biomolecular & Biomedical Science, University College Dublin, Belfield, Dublin 4, Ireland.
Valente EM; Neurogenetics Unit, Mendel Laboratory, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.; Department of Medicine and Surgery, University of Salerno, Salerno, Italy.
Leroux MR; Department of Molecular Biology and Biochemistry and Centre for Cell Biology, Development and Disease, Simon Fraser University, Burnaby, British Columbia, Canada.
Pokaż więcej
Źródło:
PLoS biology [PLoS Biol] 2016 Mar 16; Vol. 14 (3), pp. e1002416. Date of Electronic Publication: 2016 Mar 16 (Print Publication: 2016).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Caenorhabditis elegans Proteins/*metabolism
Cilia/*physiology
Membrane Proteins/*metabolism
Microtubule-Associated Proteins/*metabolism
Amino Acid Sequence ; Animals ; Caenorhabditis elegans ; Caenorhabditis elegans Proteins/genetics ; Cyclin-Dependent Kinases/metabolism ; Humans ; Membrane Proteins/genetics ; Molecular Sequence Data ; Orofaciodigital Syndromes/genetics
SCR Disease Name:
Orofaciodigital syndrome 6
Czasopismo naukowe
Tytuł:
The oral-facial-digital syndrome gene C2CD3 encodes a positive regulator of centriole elongation.
Autorzy:
Thauvin-Robinet C; 1] Equipe d'Accueil 4271 Génétique des Anomalies du Développement, Fédération Hospitalo-Universitaire, Université de Bourgogne, Dijon, France. [2] Centre de Référence Maladies Rares 'Anomalies du Développement et Syndromes Malformatifs' de l'Est, Centre de Génétique et Pédiatrie 1, Hôpital d'Enfants, Centre Hospitalier Universitaire Dijon, Dijon, France. [3].
Lee JS; 1] Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, California, USA. [2].
Lopez E; Equipe d'Accueil 4271 Génétique des Anomalies du Développement, Fédération Hospitalo-Universitaire, Université de Bourgogne, Dijon, France.
Herranz-Pérez V; 1] Laboratorio de Neurobiología Comparada, Instituto Cavanilles, Universitat de València, Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas, Valencia, Spain. [2] Unidad Mixta de Esclerosis Múltiple y Neurorregeneración, Instituto de Investigación Sanitaria Hospital La Fe, Universitat de València, Valencia, Spain.
Shida T; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, California, USA.
Franco B; 1] Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy. [2] Department of Medical Translational Sciences, Division of Pediatrics, Federico II University of Naples, Naples, Italy.
Jego L; Equipe d'Accueil 4271 Génétique des Anomalies du Développement, Fédération Hospitalo-Universitaire, Université de Bourgogne, Dijon, France.
Ye F; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, California, USA.
Pasquier L; Centre de Référence Maladies Rares 'Anomalies du Développement et Syndromes Malformatifs' de l'Ouest, Unité Fonctionnelle de Génétique Médicale, Centre Hospitalier Universitaire Rennes, Rennes, France.
Loget P; Laboratoire d'Anatomie-Pathologie, Centre Hospitalier Universitaire Rennes, Rennes, France.
Gigot N; 1] Equipe d'Accueil 4271 Génétique des Anomalies du Développement, Fédération Hospitalo-Universitaire, Université de Bourgogne, Dijon, France. [2] Laboratoire de Génétique Moléculaire, Plateau Technique de Biologie, Centre Hospitalier Universitaire Dijon, Dijon, France.
Aral B; 1] Equipe d'Accueil 4271 Génétique des Anomalies du Développement, Fédération Hospitalo-Universitaire, Université de Bourgogne, Dijon, France. [2] Laboratoire de Génétique Moléculaire, Plateau Technique de Biologie, Centre Hospitalier Universitaire Dijon, Dijon, France.
Lopes CA; Department of Biochemistry, University of Leicester, Leicester, UK.
St-Onge J; 1] Equipe d'Accueil 4271 Génétique des Anomalies du Développement, Fédération Hospitalo-Universitaire, Université de Bourgogne, Dijon, France. [2] Laboratoire de Génétique Moléculaire, Plateau Technique de Biologie, Centre Hospitalier Universitaire Dijon, Dijon, France.
Bruel AL; Equipe d'Accueil 4271 Génétique des Anomalies du Développement, Fédération Hospitalo-Universitaire, Université de Bourgogne, Dijon, France.
Thevenon J; 1] Equipe d'Accueil 4271 Génétique des Anomalies du Développement, Fédération Hospitalo-Universitaire, Université de Bourgogne, Dijon, France. [2] Centre de Référence Maladies Rares 'Anomalies du Développement et Syndromes Malformatifs' de l'Est, Centre de Génétique et Pédiatrie 1, Hôpital d'Enfants, Centre Hospitalier Universitaire Dijon, Dijon, France.
González-Granero S; 1] Laboratorio de Neurobiología Comparada, Instituto Cavanilles, Universitat de València, Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas, Valencia, Spain. [2] Unidad Mixta de Esclerosis Múltiple y Neurorregeneración, Instituto de Investigación Sanitaria Hospital La Fe, Universitat de València, Valencia, Spain.
Alby C; 1] INSERM U781, Institut IMAGINE, Hôpital Necker-Enfants Malades, Paris, France. [2] Paris Descartes-Sorbonne Paris Cité University, Institut IMAGINE, Paris, France.
Munnich A; 1] INSERM U781, Institut IMAGINE, Hôpital Necker-Enfants Malades, Paris, France. [2] Paris Descartes-Sorbonne Paris Cité University, Institut IMAGINE, Paris, France. [3] Département de Génétique, Hôpital Necker-Enfants Malades, Paris, France.
Vekemans M; 1] INSERM U781, Institut IMAGINE, Hôpital Necker-Enfants Malades, Paris, France. [2] Paris Descartes-Sorbonne Paris Cité University, Institut IMAGINE, Paris, France. [3] Département de Génétique, Hôpital Necker-Enfants Malades, Paris, France.
Huet F; 1] Equipe d'Accueil 4271 Génétique des Anomalies du Développement, Fédération Hospitalo-Universitaire, Université de Bourgogne, Dijon, France. [2] Centre de Référence Maladies Rares 'Anomalies du Développement et Syndromes Malformatifs' de l'Est, Centre de Génétique et Pédiatrie 1, Hôpital d'Enfants, Centre Hospitalier Universitaire Dijon, Dijon, France.
Fry AM; Department of Biochemistry, University of Leicester, Leicester, UK.
Saunier S; 1] Paris Descartes-Sorbonne Paris Cité University, Institut IMAGINE, Paris, France. [2] INSERM, UMRS 1163, Laboratory of Inherited Kidney Diseases, Paris, France.
Rivière JB; 1] Equipe d'Accueil 4271 Génétique des Anomalies du Développement, Fédération Hospitalo-Universitaire, Université de Bourgogne, Dijon, France. [2] Laboratoire de Génétique Moléculaire, Plateau Technique de Biologie, Centre Hospitalier Universitaire Dijon, Dijon, France.
Attié-Bitach T; 1] INSERM U781, Institut IMAGINE, Hôpital Necker-Enfants Malades, Paris, France. [2] Paris Descartes-Sorbonne Paris Cité University, Institut IMAGINE, Paris, France. [3] Département de Génétique, Hôpital Necker-Enfants Malades, Paris, France.
Garcia-Verdugo JM; 1] Laboratorio de Neurobiología Comparada, Instituto Cavanilles, Universitat de València, Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas, Valencia, Spain. [2] Unidad Mixta de Esclerosis Múltiple y Neurorregeneración, Instituto de Investigación Sanitaria Hospital La Fe, Universitat de València, Valencia, Spain.
Faivre L; 1] Equipe d'Accueil 4271 Génétique des Anomalies du Développement, Fédération Hospitalo-Universitaire, Université de Bourgogne, Dijon, France. [2] Centre de Référence Maladies Rares 'Anomalies du Développement et Syndromes Malformatifs' de l'Est, Centre de Génétique et Pédiatrie 1, Hôpital d'Enfants, Centre Hospitalier Universitaire Dijon, Dijon, France.
Mégarbané A; Unité de Génétique Médicale, Faculté de Médecine, Université Saint-Joseph, Beirut, Lebanon.
Nachury MV; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, California, USA.
Pokaż więcej
Źródło:
Nature genetics [Nat Genet] 2014 Aug; Vol. 46 (8), pp. 905-11. Date of Electronic Publication: 2014 Jul 06.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Centrioles/*genetics
Microtubule-Associated Proteins/*genetics
Orofaciodigital Syndromes/*genetics
Cell Line ; Child, Preschool ; Genetic Predisposition to Disease ; HEK293 Cells ; Humans ; Male ; Microcephaly/genetics ; Proteins/genetics
Czasopismo naukowe
    Wyświetlanie 1-10 z 10

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies